Epigenetic inactivation of RUNX3 in colorectal cancer

Eung Jin Shin1, Han Jo Kim2, Myoung Won Son1

  • 1Department of Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea.

Abstract

Insights

RUNX3 hypermethylation is linked to poor prognosis in colorectal cancer (CRC). This epigenetic change, not RUNX3 expression, may predict outcomes in CRC patients, highlighting its clinical significance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Runt-related transcription factor 3 (RUNX3) acts as a tumor suppressor gene in various cancers.
  • The clinical impact of RUNX3 inactivation in colorectal cancer (CRC) requires further elucidation.

Purpose of the Study:

  • To investigate the association between clinicopathological factors and RUNX3 promoter hypermethylation and RUNX3 gene expression in CRC patients.

Main Methods:

  • Analyzed 62 CRC tissue samples using methylation-specific PCR for RUNX3 promoter hypermethylation.
  • Assessed RUNX3 mRNA expression via reverse transcriptase-PCR and protein levels through immunohistochemical staining.

Main Results:

  • RUNX3 promoter hypermethylation was observed in 32.3% of CRC samples.
  • Hypermethylation correlated significantly with vascular invasion (P=0.006) and lymphatic invasion (P=0.002).
  • RUNX3 hypermethylation was associated with poorer survival outcomes (P=0.038), while RUNX3 expression was not a prognostic factor (P=0.363).

Conclusions:

  • RUNX3 promoter hypermethylation may serve as a predictive biomarker for poor prognosis in colorectal cancer.

Related Concept Videos

X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.7K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.6K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K